Inhibition of ceramide kinase (CERK), a kinase associated with the generation of ceramide-1-phosphate (C1P), was explored in non-small cell lung cancer (NSCLC) cells harboring KRAS mutations. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.